发明名称 Therapeutic low density lipoprotein-related protein 6 (LRP6) multivalent antibodies
摘要 The present disclosure relates to an antibody or antigen binding fragment having at least two receptor binding domains for two different binding sites of LRP6 and compositions and methods of use thereof.
申请公布号 US9290573(B2) 申请公布日期 2016.03.22
申请号 US201113696372 申请日期 2011.05.05
申请人 NOVARTIS AG 发明人 Cong Feng;Ettenberg Seth;Jenkins David;Lei Ming;Loew Andreas;Vincent Karen;Zhou Li
分类号 C07K16/28;C07K16/46;A61K39/395;A61K39/00 主分类号 C07K16/28
代理机构 代理人 Prince John
主权项 1. An isolated multivalent antibody or antigen-binding fragment thereof having at least two receptor binding domains for two different binding sites of a low density lipoprotein-related protein 6 (LRP6) target receptor, wherein the first receptor binding domain binds to a first binding site on the target receptor and the second receptor binding domain binds to a second binding site on the same LRP6 target receptor, wherein the first and second receptor binding domains are linked together such that the binding of the first and second receptor binding domains to the first and second binding sites of the LRP6 target receptor inhibits a canonical Wnt signal transduction pathway, and wherein the antibody or antigen binding fragment displays no significant potentiation of a Wnt signal; wherein the first receptor binding domain is an IgG antibody and the second receptor binding domain is an scFv fragment, wherein the IgG antibody and scFv fragment are linked together by a linker with a spatial distribution that permits the IgG antibody and scFv fragment to bind to the first and second epitopes of LRP6, respectively; andwherein the heavy chain of the IgG antibody is selected from the group consisting of SEQ ID NO: 18, 66, and 86, and the light chain is selected from the group consisting of SEQ ID NO: 17, and 85.
地址 BASEL CH